NCT02268474

Excel V 532 nm KTP Laser for Treatment of Erythematotelangiectatic Rosacea & Papulopustular Rosacea

Prospective, Randomized, Controlled Split-Face Study of the Excel V 532nm KTP Laser for the Treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Cutera Inc. · Industry
• Sex: Female
• Age: 20 Years – 80 Years
• Healthy volunteers: Accepted

Summary

A single center prospective, randomized, controlled split face study comparing a 532nm KTP laser with a 595nm PDL for the treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea. Subjects will receive laser treatments and will be followed at 6 weeks post-final laser treatment.

Detailed description

The purpose of this study is to evaluate the safety and efficacy of the 532nm KTP laser within the Cutera® Excel V system for the treatment of Erythematotelangiectatic Rosacea and Papulopustular Rosacea as compared to a 595nm Pulse Dye Laser. The objectives of this study are: 1\) To evaluate and compare the safety and efficacy of the laser treatments for Erythematotelangiectatic Rosacea and Papulopustular Rosacea at 6 weeks post final laser treatment.

Conditions

• Erythematotelangiectatic Rosacea
• Papulopustular Rosacea

Interventions

Type	Name	Description
DEVICE	532nm KTP Laser vs 595nm Pulse Dye Laser	Intervention for the Cutera Excel V system is to cease treatment to any subject that is experiencing any adverse reaction.

Timeline

• Start date: 2014-09-01
• Primary completion: 2015-08-01
• Completion: 2015-08-01
• First posted: 2014-10-20
• Last updated: 2023-02-21
• Results posted: 2023-02-21

Locations

1 site across 1 country: United States